Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

Breast Cancer Research and Treatment

Volumn 124, Issue 3, 2010, Pages 607-617

  Castellano, Isabella ^a   Allia, Elena ^a   Accortanzo, Valeria ^b   Vandone, Anna Maria ^c   Chiusa, Luigi ^a   Arisio, Riccardo ^b   Durando, Antonio ^b   Donadio, Michela ^c   Bussolati, Gianni ^a   Coates, Alan S ^d,e   Viale, Giuseppe ^f   Sapino, Anna ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Sant'Anna Hospital   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d International Breast Cancer Study Group   (Switzerland)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Androgen receptor; Breast cancer; Chemotherapy; Estrogen receptor; Prognosis

Indexed keywords

ANDROGEN RECEPTOR; ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; NAVELBINE; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RELAPSE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78249249431     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0761-y     Document Type: Article

References (27)

1. EA Rakha ME El-Sayed AR Green, et al. 2007 Prognostic markers in triple-negative breast cancer Cancer 109 25 32 1:CAS:528:DC%2BD2sXhtVKrtLY%3D 10.1002/cncr.22381 17146782 (Pubitemid 46120191)
2. W Schippinger P Regitnig N Dandachi, et al. 2006 Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer Virchows Arch 449 24 30 1:CAS:528:DC%2BD28Xmtlais7g%3D 10.1007/s00428-006-0213-6 16628414 (Pubitemid 43988362)
3. AA Peters G Buchanan C Ricciardelli, et al. 2009 Androgen receptor inhibits estrogen receptor-alfa activity and is prognostic in breast cancer Cancer Res 69 6131 6140 1:CAS:528:DC%2BD1MXpt1CgtLs%3D 10.1158/0008-5472.CAN-09- 0452 19638585
4. F Moinfar M Okcu O Tsybrovskyy, et al. 2003 Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies Cancer 98 703 711 1:CAS:528:DC%2BD3sXntVWgtbc%3D 10.1002/cncr.11532 12910513 (Pubitemid 36959265)
5. V Kuenen-Boumeester TH Van der Kwast CC Claassen, et al. 1996 The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters Eur J Cancer 32A 1560 1565 1:STN:280:DyaK2s%2FmslOksg%3D%3D 10.1016/0959-8049(96)00112-8 8911118 (Pubitemid 26279124)
6. A Sapino L Righi P Cassoni, et al. 2001 Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women Mod Pathol 14 768 776 1:STN:280:DC%2BD3MvlvFSkuw%3D%3D 10.1038/modpathol.3880387 11504836 (Pubitemid 33069835)
7. A Kollara HJ Kahn A Marks, et al. 2001 Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers Breast Cancer Res Treat 67 245 253 1:CAS:528:DC%2BD3MXntFGlt7g%3D 10.1023/A:1017938608460 11561770 (Pubitemid 32803530)
8. Y Ogawa E Hai K Matsumoto, et al. 2008 Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers Int J Clin Oncol 13 431 435 1:CAS:528:DC%2BD1cXht1OktrzL 10.1007/s10147-008-0770-6 18946753
9. Z Gatalica 1997 Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ Pathol Res Pract 193 753 758 1:CAS:528:DyaK1cXhtVygu7w%3D 9521507
10. Niemeier LA, Dabbs DJ, Beriwal S et al (2009) Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. doi: 10.1038/modpathol.2009.159
11. RM Bryan RJ Mercer RC Bennett, et al. 1984 Androgen receptors in breast cancer Cancer 54 2436 2440 1:STN:280:DyaL2M%2FkvVGlug%3D%3D 10.1002/1097- 0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H 6498736 (Pubitemid 15223385)
12. AK Agrawal M Jeleń Z Grzebieniak, et al. 2008 Androgen receptors as a prognostic and predictive factor in breast cancer Folia Histochem Cytobiol 46 269 276 10.2478/v10042-008-0039-y 19056529
13. AM Gonzalez-Angulo K Stemke-Hale SL Palla, et al. 2009 Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer Clin Cancer Res 15 2472 2478 1:CAS:528:DC%2BD1MXjvVWks7c%3D 10.1158/1078-0432.CCR- 08-1763 19276248
14. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 1:CAS:528:DC%2BD3MXntVGmsbo%3D 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
15. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10.1038/35021093 10963602
16. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 1:CAS:528:DC%2BD3sXlsFGntLk%3D 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
17. MC Cheang SK Chia D Voduc, et al. 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 736 750 1:CAS:528:DC%2BD1MXmtlyit74%3D 10.1093/jnci/djp082 19436038
18. A Sapino C Marchiò R Senetta, et al. 2006 Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure Virchows Arch 449 288 296 1:CAS:528:DC%2BD28XptF2kt7g%3D 10.1007/s00428-006-0233-2 16770642 (Pubitemid 44367968)
19. C Marchiò MB Lambros P Gugliotta, et al. 2009 Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis J Pathol 219 16 24 10.1002/path.2574 19670217
20. S Liu SK Chia E Mehl, et al. 2010 Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients Breast Cancer Res Treat 119 53 61 1:CAS:528:DC%2BD1MXhsFaqtrrI 10.1007/s10549-009-0318-0 19205877
21. AC Wolff ME Hammond JN Schwartz, et al. 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 118 145 1:CAS:528:DC%2BD2sXht1ejs7Y%3D 10.1200/JCO.2006.09.2775 17159189 (Pubitemid 350003059)
22. LM McShane DG Altman W Sauerbrei, et al. 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res treat 100 229 235 10.1007/s10549-006-9242-8 16932852 (Pubitemid 44631925)
23. Park S, Koo J, Park HS et al (2009) Expression of androgen receptors in primary breast cancer. Ann Oncol. doi: 10.1093/annonc/mdp510
24. JS Koo W Jung J Jeong 2009 The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast cancer Jpn J Clin Oncol 39 560 568 10.1093/jjco/hyp065 19531543
25. De Amicis F, Thrugnansampanthan J, Cui Y et al (2009) Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0436-8
26. A Goldhirsch JN Ingle RD Gelber, et al. 2009 Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Ann Oncol 20 1319 1329 1:STN:280: DC%2BD1Mrjtlyhug%3D%3D 10.1093/annonc/mdp322 19535820
27. JK Hess-Wilson HK Daly WA Zagorski, et al. 2006 Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult Cancer Res 66 11998 12008 1:CAS:528:DC%2BD28Xhtlagu7nE 10.1158/0008-5472.CAN-06-2249 17178899 (Pubitemid 46094214)